Skip to main content


Page 13 of 13

  1. The cyclin-dependent kinase inhibitor p27Kip1 functions during normal cerebellar development and has demonstrated tumor suppressor functions in mouse models of medulloblastoma. Because P27 loss is associated with...

    Authors: Beryl A Hatton, David W Ellison, Amar Gajjar, Marcel Kool, Matthew Fero and James M Olson
    Citation: Biomarker Research 2013 1:14
  2. Endometrial cancer (EC) is the leading malignant tumor occurring in the female genital tract and some subtypes are highly invasive and metastatic. miRNAs are small non-coding RNAs that have a broad impact on c...

    Authors: Haiyan Zhai, Mihriban Karaayvaz, Peixin Dong, Noriaki Sakuragi and Jingfang Ju
    Citation: Biomarker Research 2013 1:12
  3. IK is a nuclear protein containing a unique domain named RED due to the presence of a repetitive arginine (R), aspartic (E), and glutamic acid (D) sequence. To date, the function of this protein remains largel...

    Authors: Liyan Hu, Feikun Yang, Xianan Liu, Dazhong Xu and Wei Dai
    Citation: Biomarker Research 2013 1:11
  4. Diabetic kidney disease is the leading cause of end-stage renal disease in developed and developing countries. Microalbuminuria is the gold standard for detection and prediction of diabetic kidney disease and ...

    Authors: Cheng Wang, CuiCui Li, WenYu Gong and Tanqi Lou
    Citation: Biomarker Research 2013 1:9
  5. Metabolic alteration is one of the hallmarks of carcinogenesis. We aimed to identify certain metabolic biomarkers for the early detection of pancreatic cancer (PC) using the transgenic PTEN-null mouse model. P...

    Authors: He N Xu, Shoko Nioka and Lin Z Li
    Citation: Biomarker Research 2013 1:6
  6. Despite several decades of intensive effort to improve the imaging techniques for lung cancer diagnosis and treatment, primary lung cancer is still the number one cause of cancer death in the United States and...

    Authors: Dong Xiang, Bicheng Zhang, Donald Doll, Kui Shen, Goetz Kloecker and Carl Freter
    Citation: Biomarker Research 2013 1:4

Annual Journal Metrics

  • 2022 Citation Impact
    11.1 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    1.808 - SNIP (Source Normalized Impact per Paper)
    2.379 - SJR (SCImago Journal Rank)

    2023 Speed
    7 days submission to first editorial decision for all manuscripts (Median)
    72 days submission to accept (Median)

    2023 Usage
    353 Altmetric mentions